2016-03-11 Maarten Bijlsma
Prof dr E Hak
Prof dr S Vansteelandt
Age-period-cohort methodology: Confounding by birth cohort in cardiovascular pharmacoepidemiology

2016-03-02 Linda de Jong
Prof dr IM van Langen
Prof dr LTW de Jong- van den Berg
Data quality and methodology in studies on maternal medication use in relation to congenital anomalies

2016-02-26 Dianna de Vries
Prof dr E Hak
Prof dr P Denig
Prof dr MJ Postma
Statin treatment in type 2 diabetes patients

2016-02-19 Bianca Mulder
Prof dr E Hak
Prof dr SS Jick
Medication use during pregnancy and atopic diseases in childhood

2016-01-25 Priscilla Zetstra-van der Woude
Prof dr LTW de Jong-van den Berg
Data collection on risk factors in pregnancy

2015-12-04 Koen Pouwels
Prof dr E Hak
Self-controlled designs to control confounding

2015-09-25 Job van Boven
Prof dr MJ Postma
Prof dr T van der Molen
Enhancing adherence in patients with COPD: Targets, interventions & cost-effectiveness

2014-05-28 Giedre Gefenaite
Prof dr E Hak
Prof dr RP Stolk
Newly introduced vaccines. Effectiveness and deterninants of acceptance

2013-05-31 Josta de Jong
Prof dr LTW de Jong-van den Berg
Dr TW de Vries
Antibiotic drug use in children. Pharmacoepidemiologic, practical, social en enviromental perspectives in the Netherlands

2013-02-25 Mark Rozenbaum
Prof dr MJ Postma
Prof dr E Hak
Cost and Effectiveness of Extended Vaccination Strategies against Pertussis and Pneumococcal Disease

2013-01-11 Peter ter Horst
Prof dr B Wilffert
Prof dr LTW de Jong-van den Berg
Clinical Pharmacology of Antidepressants During Pregnancy

2012-11-16 Ineke Crijns
Prof dr LTW de Jong-van den Berg
Drug Related Safety Issues Affecting Precnancy Outcome and Concerning Risk Minimisation Measures. Emphasis on Pregnancy Prevention Programmes

2012-03-16 Stefan Vegter
Prof dr MJ Postma
Prof dr G Navis
The value of personalized approaches to improve pharmacotherapy in renal disease

2012-02-24 Silvia Ravera
Prof dr JJ de Gier
Prof dr LTW de Jong vd berg
Psychotropic medications and traffic safety. Contributions to risk assessment and risk communication

2011-12-09 Janneke Boersma-Jentink
Prof dr LTW de Jong vd berg
Prof dr H Dolk
Risk assessment of antiepileptic drugs in pregnancy

2010-01-11 Marian K. Bakker
prof dr  CHCM Buijs
Prof dr LTW de Jong van den berg
The use of a birth defects case-control monitoring system in studying the safety of medication use in pregnancy.

2009-06-12 Cornelis Boersma
Prof dr MJ Postma
Prof dr LTW de Jong van den berg
Prof dr PE de Jong
Health economics of cardiovascular & renal disease prevention : from clinical trials to real-life settings.

2009-03-20 Fokaline Vroom
Prof dr LTW de Jong-van den Berg
Prof dr JRBJ Brouwers
Prof dr MAFJ van de Laar
Drug use in pregnancy. Exploring the field of DMARDs in pregnancy.

2006-09-15 Jarir Atthobari
prof dr LTW de Jong-van den Berg
prof dr PE de Jong
Drug use in a population screening: Pharmacoepidemiological and pharmacoeconomical aspects.

2006-06-30 Rogier Klok
Prof dr JRBJ Brouwers
Prof dr MJ Postma
Pharmacoeconomic Analysis of Proton Pump Inhibitor Therapy and interventions to Control Helicobacter pylori Infection.

2006-10-02 Adrianne Faber
prof dr LTW de Jong-van den Berg
Stimulant treatment in children: a Dutch perspective.

2006-12-08 Willemijn Meijer
prof dr LTW de Jong-van den Berg
prof dr JRBJ Brouwers
Drug safety in pregnancy. Studying and communicating teratogenic risks.

2003-10-03 Claudia Rijcken
Prof dr LTW de Jong-van den Berg
Pharmacy Data as a Tool for assessing Antypsychotic Drug Use.

2003-10-03 Eric Schirm
Prof dr LTW de Jong-van den Berg
Dr H Tobi Drug
Exposure from conception till adulthood.